SMAD9 and pulmonary arterial hypertension: Furthermore, we describe the clinical features of families with confirmed familial aggregation of PAH but no detectable mutations of the BMPR2 gene and tested these families for mutations of the genes ACVRL1, Endoglin, and SMAD8.